Filing Details
- Accession Number:
- 0001022079-18-000088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-06 19:39:53
- Reporting Period:
- 2018-03-02
- Accepted Time:
- 2018-03-06 19:39:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1599837 | E. J. Davis | 500 Plaza Drive Secaucus NJ 07094 | Evp, General Diagnostics | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-02 | 11,886 | $101.00 | 48,909 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2018-03-02 | 6,764 | $101.00 | 42,189 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2018-03-05 | 5,122 | $101.00 | 37,067 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 23, 2015, approved in accordance with the requirements of Rule 16b-3(d).
- Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.
- The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
- The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017.
Billionaire Hedge Funds
